How Can We Help You?

When you partner with ValSource, you partner with leaders in risk management, process validation, and continued verification. We stand with you every step of the way.

ValSource Corporate Contact Information

  • 610.269.2808
  • 918A Horseshoe Pike,
    Downingtown, PA 19335

Resource Center

ValSource Viewpoints

Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.

ValSource Viewpoints

Reflections from the PDA ATMP/CGT October 2021 Conference
December 20, 2021

Continue listening to our podcast series focused on Advanced Therapeutic Medical Products (ATMPs), including cell and gene therapies. Today’s topic is a look-back at the October 2021 ATMP/CGT meeting hosted by the PDA - Parenteral Drug Association – with our panel of experts Darius Pillsbury, Kelly Waldron, PhD, and Virginia Andreotti-Jones.

ATMP/CGT Contamination Control Strategies
November 18, 2021

This is the 5th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that includes cell and gene therapies. Specifically, we'll be discussing ATMP/CGT and Contamination Control strategies.

ATMPs Third Parties
October 11, 2021

In the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that includes cell and gene therapies, we'll be discussing ATMP/CGT and working with third parties.

On ATMPs: Regulations and Expectations
August 20, 2021

Continue the ATMP discussion with our experts. This episode is focused on working with third parties, what regulations and expectations are out there now, and what might be coming around the corner.

On ATMPs: Phase Appropriate Quality Systems
June 25, 2021

Listen & Learn. ValSource experts explore Phase Appropriate GMPs as they apply to Advanced Therapeutic Medical Products or ATMPs.

ATMP, Cell & Gene Therapies Series Introduction
June 18, 2021

Meet the Experts! The first episode in the Advanced Therapeutic Medicinal Products or ATMPs series, including Cell & Gene Therapies.

Articles & News

Press, updates, and more important information.

Articles & News

Valid Insights

Read the latest in industry breakthroughs.

Valid Insights

Annex 1 revision experts.

Our consultants are highly-recognized for their Annex 1 knowledge and expertise. We provide a plan forward through Annex 1 updates, today and into the future.